Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name RO7122290
Trade Name
Synonyms RO 7122290|RO-7122290
Drug Descriptions

RO7122290 is a fusion protein consisting of a ligand of TNFRS9 fused to a Fab fragment targeting FAP, which may lead to activation of anti-tumor immune response against FAP-expressing tumor cells (Ann Oncol Sep 2020, 31 (Suppl 4), S707).

DrugClasses
CAS Registry Number NA
NCIT ID C175490

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + RO7122290 Atezolizumab RO7122290 0 0
Obinutuzumab + RO6958688 + RO7122290 Obinutuzumab RO6958688 RO7122290 0 1
RO7122290 RO7122290 0 0


Additional content available in CKB BOOST